LPL Financial’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.58M | Buy |
122,861
+2,564
| +2% | +$32.7K | ﹤0.01% | 3729 |
|
|
2025
Q4 | $1.08M | Buy |
120,297
+17,262
| +17% | +$238K | ﹤0.01% | 3992 |
|
|
2025
Q3 | $1.78M | Buy |
103,035
+39,082
| +61% | +$481K | ﹤0.01% | 3419 |
|
|
2025
Q2 | $600K | Buy |
63,953
+9,249
| +17% | +$76K | ﹤0.01% | 4226 |
|
|
2025
Q1 | $389K | Buy |
54,704
+663
| +1% | +$6.7K | ﹤0.01% | 4389 |
|
|
2024
Q4 | $630K | Sell |
54,041
-2,554
| -5% | -$39.9K | ﹤0.01% | 3891 |
|
|
2024
Q3 | $1.16M | Sell |
56,595
-731
| -1% | -$16.9K | ﹤0.01% | 3252 |
|
|
2024
Q2 | $1.28M | Buy |
57,326
+5,735
| +11% | +$137K | ﹤0.01% | 3016 |
|
|
2024
Q1 | $1.42M | Buy |
51,591
+5,055
| +11% | +$140K | ﹤0.01% | 2865 |
|
|
2023
Q4 | $1.42M | Buy |
46,536
+1,738
| +4% | +$50K | ﹤0.01% | 2725 |
|
|
2023
Q3 | $1.42M | Buy |
44,798
+219
| +0.5% | +$8.5K | ﹤0.01% | 2601 |
|
|
2023
Q2 | $1.82M | Buy |
44,579
+5,998
| +16% | +$243K | ﹤0.01% | 2336 |
|
|
2023
Q1 | $1.44M | Buy |
38,581
+2,590
| +7% | +$102K | ﹤0.01% | 2445 |
|
|
2022
Q4 | $1.26M | Sell |
35,991
-3,776
| -9% | -$180K | ﹤0.01% | 2464 |
|
|
2022
Q3 | $2.23M | Sell |
39,767
-2,056
| -5% | -$128K | ﹤0.01% | 1898 |
|
|
2022
Q2 | $2.17M | Buy |
41,823
+912
| +2% | +$46.3K | ﹤0.01% | 1964 |
|
|
2022
Q1 | $2.97M | Sell |
40,911
-3,732
| -8% | -$316K | ﹤0.01% | 1762 |
|
|
2021
Q4 | $5.28M | Buy |
44,643
+891
| +2% | +$112K | ﹤0.01% | 1427 |
|
|
2021
Q3 | $5.87M | Buy |
43,752
+1,817
| +4% | +$275K | 0.01% | 1292 |
|
|
2021
Q2 | $6.79M | Sell |
41,935
-11,826
| -22% | -$921K | 0.01% | 1140 |
|
|
2021
Q1 | $4.32M | Buy |
53,761
+10,454
| +24% | +$702K | 0.01% | 1324 |
|
|
2020
Q4 | $2.36M | Buy |
43,307
+12,460
| +40% | +$452K | ﹤0.01% | 1570 |
|
|
2020
Q3 | $613K | Buy |
30,847
+4,406
| +17% | +$91.9K | ﹤0.01% | 2310 |
|
|
2020
Q2 | $556K | Buy |
26,441
+14,409
| +120% | +$245K | ﹤0.01% | 2299 |
|
|
2020
Q1 | $147K | Buy |
+12,032
| New | +$162K | ﹤0.01% | 2902 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
